Correlation Between Abattis Bioceuticals and Axon Enterprise

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abattis Bioceuticals and Axon Enterprise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abattis Bioceuticals and Axon Enterprise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abattis Bioceuticals Corp and Axon Enterprise, you can compare the effects of market volatilities on Abattis Bioceuticals and Axon Enterprise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abattis Bioceuticals with a short position of Axon Enterprise. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abattis Bioceuticals and Axon Enterprise.

Diversification Opportunities for Abattis Bioceuticals and Axon Enterprise

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Abattis and Axon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abattis Bioceuticals Corp and Axon Enterprise in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axon Enterprise and Abattis Bioceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abattis Bioceuticals Corp are associated (or correlated) with Axon Enterprise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axon Enterprise has no effect on the direction of Abattis Bioceuticals i.e., Abattis Bioceuticals and Axon Enterprise go up and down completely randomly.

Pair Corralation between Abattis Bioceuticals and Axon Enterprise

If you would invest  27,853  in Axon Enterprise on September 1, 2024 and sell it today you would earn a total of  36,843  from holding Axon Enterprise or generate 132.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Abattis Bioceuticals Corp  vs.  Axon Enterprise

 Performance 
       Timeline  
Abattis Bioceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abattis Bioceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Abattis Bioceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Axon Enterprise 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Axon Enterprise are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axon Enterprise displayed solid returns over the last few months and may actually be approaching a breakup point.

Abattis Bioceuticals and Axon Enterprise Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abattis Bioceuticals and Axon Enterprise

The main advantage of trading using opposite Abattis Bioceuticals and Axon Enterprise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abattis Bioceuticals position performs unexpectedly, Axon Enterprise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axon Enterprise will offset losses from the drop in Axon Enterprise's long position.
The idea behind Abattis Bioceuticals Corp and Axon Enterprise pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets